Randomised natalizumab discontinuation study: taper protocol may prevent disease reactivation

Bianca Weinstock-Guttman, Jesper Hagemeier, Katelyn S Kavak, Vasu Saini, Kara Patrick, Deepa P Ramasamy, Muhammad Nadeem, Ellen Carl, David Hojnacki, Robert Zivadinov
  • Journal of Neurology Neurosurgery & Psychiatry, January 2016, BMJ
  • DOI: 10.1136/jnnp-2015-312221

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1136/jnnp-2015-312221

The following have contributed to this page: Dr muhammad nadeem